Vizamyl 150MBq/ml, Injektionslösung

7680661100023 CH-66110 Injektionslösung
Vizamyl 150MBq/ml, Injektionslösung
Vizamyl 150MBq/ml, Injektionslösung
Vizamyl 150MBq/ml, Injektionslösung
1 / 3
google

Article details

Package size
15
Selling units
15
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
11/12/2020
Summary of Product Characteristics
Français
11/12/2020
Summary of Product Characteristics
Italien
11/12/2020

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MBQ Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.07 ML Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.1 MG Substance HBESI

Authorization holder

GE Healthcare AG

8152 Opfikon

Authorization information

Swissmedic authorization number
66110
Drug name
Vizamyl, Injektionslösung
Galenic form
LSPA
ATC Code
V09AX04
Authorization status
Z
Dispensing category
A
First authorization
12/04/2017
Authorization expiration date
31/12/9999
IT Number
17.01.1.
Domain
Human medicine
Field of application
PET-Diagnose für die Alzheimer-Krankheit

Package details

Description (FR)
VIZAMYL sol inj 150 MBq/ml 15ml flac
Description (DE)
VIZAMYL Inj Lös 150 MBq/ml 15ml Durchstf
Market launch
12/04/2017
Narcotic (BTM)
No

Other package sizes (1)

VIZAMYL sol inj 150 MBq/ml 10ml flac
10 ML
GTIN: 7680661100016
View